趙海濤，1972年生，籍貫天津市，北京協和醫院肝臟外科主任醫師，博士生導師。1989年考入北京醫科大學臨床醫學專業，1994年獲得學士學位。2001年在北京大學醫學部外科學專業攻讀碩士學位，從事臨床醫學研究。2010年在北京協和醫學院外科學專業攻讀博士學位，從事外科學研究。2010年升為副主任醫師。2017年升為主任醫師。

研究方向專注于肝癌的基礎研究與臨床應用研究，主要研究興趣在于通過高通量測序研究肝膽系統惡性腫瘤發病機制、基因分型，鑒定腫瘤治療靶點，應用于臨床的精準醫療轉化研究。團隊長期致力于肝膽惡性腫瘤的靶向免疫治療、基因組學、腫瘤異質性及起源重大臨床科研問題。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Lin J#, Peng X#, Dong K#, Long J#, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H*, Liang H*.Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nature Communications. 2021 Aug 6;12(1):4753. (IF=14.919)

2. Long J#, Huang S#, Bai Y#, Mao J#, Wang A, Lin Y, Yang X, Wang D, Lin J, Bian J, Yang X, Sang X*, Wang X*, Zhao H*. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis., Brief Bioinform, 2021, 20(22): 224. (IF=11.622)

3. Yang X#, Hu Y#, Yang K#, Wang D#, Lin J, Long J, Xie F, Mao J, Bian J, Guan M, Pan J, Huo L, Hu K, Yang X, Mao Y, Sang X, Zhang J, Wang X*, Zhang H*, Zhao H*. Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers. J Immunother Cancer. 2021 May;9(5):e001942. (IF=13.751)

4. Lin J#, Cao Y#, Yang X#, Li G, Shi Y, Wang D, Long J, Song Y, Mao J, Xie F, Bai Y, Zhang L, Yang X, Wan X, Wang A, Guan M, Zhao L, Hu K, Pan J, Huo L, Lu X, Mao Y, Sang X, Zhang H*, Wang K*, Wang X*, Zhao H*.Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics. 2021 Mar 4;11(10):4585-4598 . (IF=11.556)

5. Lin J#, Shi J#, Guo H#, Yang X, Jiang Y, Long J, Bai Y, Wang D, Yang X, Wan X, Zhang L, Pan J, Hu K, Guan M, Huo L, Sang X, Wang K*, Zhao H*.Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clin Cancer Res. 2019 Aug 1;25(15):4701-4711. (IF=10.107)

6. Long J#, Wang A#, Bai Y#, Lin J, Yang X, Wang D, Yang X, Jiang Y, Zhao H*. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019 Apr;42:363-374. (IF=8.143, ESI)

7. Wang A#, Wu L#, Lin J#, Han L, Bian J, Wu Y, Robson SC, Xue L, Ge Y, Sang X*, Wang W*, Zhao H*.Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. Nature Communications. 2018 Mar 1;9(1):894. (IF=11.878)

8. Long J#, Lin J#, Wang A#, Wu L, Zheng Y, Yang X, Wan X, Xu H, Chen S, Zhao H. PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. J Hematol Oncol. 2017 Aug 3;10(1):146. (IF=7.333)

9. Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H*, Teschendorff AE*. dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res. 2017 Jan 4;45(D1):D812-D818.  (IF=11.162)

10. Long J#, Lin J#, Wang A#, Wu L, Zheng Y, Yang X, Wan X, Xu H*, Chen S*, Zhao H*.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis. Journal of Hepatology 2014 Oct;61(4):840-849. (IF=11.336)